Intensive Care Medicine

, Volume 38, Issue 2, pp 192–209 | Cite as

Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals

  • Massimo AntonelliEmail author
  • Marc Bonten
  • Jean Chastre
  • Giuseppe Citerio
  • Giorgio Conti
  • J. Randall Curtis
  • Daniel De Backer
  • Goran Hedenstierna
  • Michael Joannidis
  • Duncan Macrae
  • Jordi Mancebo
  • Salvatore M. Maggiore
  • Alexandre Mebazaa
  • Jean-Charles Preiser
  • Patricia Rocco
  • Jean-François Timsit
  • Jan Wernerman
  • Haibo Zhang
Open Access
Year in Review 2011


Mean Arterial Pressure Acute Lung Injury Levosimendan Esmolol Multiple Organ Dysfunction Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


A number of articles have been published in the fields of neurology, nutrition, epidemiology, nephrology, and ethics, together with interesting experimental investigations. This year, we wanted to integrate the works published in Intensive Care Medicine with the most relevant papers in these various fields published in other distinguished journals.


Acute kidney injury continued to be hot topic in 2011. Early diagnosis remains an issue of increasing importance, with the aim being to install early preventive measures in critically ill patients. Several very promising biomarkers turned out to have serious limitations in specific disease states, e.g. NGAL in septic shock [1, 2]. Cystatin C is another biomarker that is presumed to allow the early detection of small declines in glomerular filtration rate (GFR), but may also reflect tubular damage if measured in the urine. Royakkers et al. [3] investigated both urine and serum cystatin c in a multicentre prospective observational trial including 151 patients, and could not detect any diagnostic value for urinary cystatin c, only a very moderate performance of serum cystatin c for the prediction of AKI (AUC 0.72), and a very poor one for predicting the requirement for renal replacement therapy RRT (renal replacement therapy) (AUC ≤0.66). Serum cystatin C may also be futile as a biomarker for AKI (acute kidney injury) in the setting of renal obstruction [4].

Discrimination between transient and persistent AKI is of clinical relevance but currently often based on urinary indices which are not very reliable in critically ill patients. Darmon et al. [5] used a different approach by determining Doppler resistive indices in 51 patients. They found that a RI >0.795 predicted persistent AKI with an OR of 1.85 (95% CI 1.2–2.85) upon applying logistic regression analysis. Considering the large influence of interobserver variability on this method, larger multicentre trials are required to prove the utility of this method in daily clinical practice.

The question of the optimal mean arterial pressure to optimise renal perfusion and renal function is still unresolved. Redfors et al. [6] approached this question in an elegant crossover study including 12 postcardiac surgery patients with norepinephrine-dependent vasodilatory shock. Increasing the target mean arterial pressure (MAP) from 60 to 75 mmHg resulted in significantly improved GFR (27%) and urinary output associated with increased oxygen delivery (13%) and reduced renal oxygen consumption. A further increase of MAP to 90 mmHg was ineffective or even detrimental for these parameters. The results indicate severely disturbed autoregulation of the kidney in vasodilatory shock and possible benefits from targeting a higher MAP of around 75 mmHg.

Three studies investigated the epidemiology of AKI of specific aetiologies. Hoste et al. [7] examined the incidence of contrast-media induced AKI (CI-AKI) in 787 predominantly surgical (~75%) patients. As opposed to data obtained from non-critically ill patients, the authors found a near-threefold increased incidence, with rates of between 16 and 23% depending on the definition used. Contrast-induced AKI was associated with a significantly increased length of stay, higher requirements for renal replacement therapy and mortality (1-year mortality 55.5 vs. 24% in patients without CI-AKI). Decreased renal function at the time of intervention, lower mean arterial pressure, vasoactive therapy, and administration of diuretics were found to be major risk factors for CI-AKI. This study, currently the largest of its kind, underlines the importance of nephrotoxic medication in this specifically vulnerable group of patients, and sets the stage for future randomised trials investigating effective preventive measures against CI-AKI.

Pettila et al. [8] and Nin et al. [9] reported the epidemiology of AKI associated with severe H1N1 infections in different parts of the world. They found incidence rates of AKI of between 34 and 51%, demonstrating the high frequency of this complication in patients suffering from H1N1 infection. The occurrence of AKI was associated with a significantly increased risk of hospital mortality. Nin et al. specifically addressed the question of early AKI versus late AKI (after ICU day 2), and found a worse outcome for the latter, indicating that a large proportion of early AKI occurring in the context of H1N1 infection is presumably due to pre-renal factors like dehydration or hypotension, which can be easily corrected, resulting in rapid renal recovery. However, as demonstrated in accompanying correspondence by Nin et al. [10], viral particles could also be found within renal tissue obtained from a few biopsies, which possibly contributed to AKI. These studies provide further insight into the pathophysiology of AKI in the setting of severe viral infections; it is most probably a mixture of pre-renal causes combined with endothelial damage and severe disturbance of the coagulation system caused by exaggerated inflammatory response and finally complicated by secondary bacterial infections. Direct renal effects of viral infiltration of the kidney, however, appear to be a very rare mechanism for AKI [11].

Sepsis is considered a well-established risk factor for AKI, with sepsis-associated AKI showing a very modest prognosis, substantiated by mortality rates of up to 75% [12]. On the other hand, AKI itself is considered a systemic disease associated with impaired immune function. Mehta et al. [13] investigated the frequency and the clinical consequences when sepsis developed as a complication of AKI in 618 critically ill patients from the multicentre PICARD study. They found that about 40% of the patients developed sepsis at a median of 5 days after AKI, with similar consequences for outcome as seen in sepsis-associated AKI itself. This study demonstrates the importance of preventing AKI as well as taking measures against infections in patients already suffering from AKI to avoid consecutive development of sepsis.

Another condition in which alterations in patients’ immune response may significantly influence outcome is liver cirrhosis. Berry et al. [14] showed that a reduction in HLA-DR expression by monocytes to less than 40% of admission values was highly correlated with increased 90-day mortality. The changes in HLA-DR expression were also associated with reduced Th1 response to antigenic stimulation and exaggerated secretion of the anti-inflammatory cytokines IL-10 and IFN-γ.


Three epidemiologic studies investigated the outcomes of postsurgical patients admitted to the ICU. Analysing the data for 88,504 patients collected from several Austrian ICUs over a period of 11 years, Rhodes et al. [15] found that pre-existing morbidities such as chronic renal disease, respiratory or cardiac failure, cirrhosis, alcoholism, acute kidney injury or nonmetastatic cancer significantly impaired outcome. Independent from those risks, reason for admission, urgency of operation, age and SAPS II score turned out to be major factors associated with hospital mortality. An interesting observation was the fact that survival had improved over the investigated period of 11 years.

Another important risk factor for increased morbidity and mortality appears to be postoperative red blood cell transfusion, as shown by Mohnle et al. [16], who analysed a cohort of 945 patients with a low-to-moderate risk profile after coronary artery bypass grafting among 5,436 patients enrolled in an international multicentre trial. Patients receiving red blood cell transfusions had a higher likelihood of experiencing cardiac events or harvest site infections, and suffered from impaired composite morbidity outcome which included hospital mortality, renal failure, pneumonia and mediastinitis.

An increased body mass index may be protective in surgical intensive care unit patients. Hutagalung et al. [17, 18] analysed ICU and hospital mortality in 9,935 patients, and found that both overweight (BMI 25–29.9 kg/m2) and obese (BMI 30–39.9 kg/m2) patients showed a significantly lower 60-day hospital mortality than very obese and even normal weight patients. Interestingly, the improved survival prevailed despite a higher incidence of AKI in these specific weight groups, as already shown in another recent study [18].

The association of older age and outcome with prolonged ICU stay was investigated in a cohort of 11,395 cardiac surgery patients by Ettema et al. [19]. The authors were able to demonstrate that all three major currently applied prediction models for outcome—the Parsonnet model, the Huijskes model and the EuroSCORE—showed poor calibration with age >70 and decreasing discrimination, which was worst for age >80 (AUCs were 0.68, 0.69 and 0.64, respectively). Obviously, outcome and recovery in older patients is rather more dependent on their general condition than on the conventional parameters used for scoring systems.

Predictors of mortality

Simple, widely available lab tests could represent useful markers and predictors of outcome in ICU patients, especially when a strong rationale supports their potential prognostic value. For instance, eosinophil count is tightly and readily regulated by cytokines and is related to the stimulation of the adrenal axis. Likewise, the presence of eosinopenia has already been reported as a marker of infection. In a large prospective study, Abidi et al. [20] evaluated the prognostic value of serial eosinophil count measured daily from ICU admission until the seventh day of stay in 200 patients. The absolute eosinophil count was lower over the entire ICU stay in nonsurvivors. Eosinopenia (<40 cells/mm3) was found to be an independent predictor of ICU mortality, with an area under the ROC curve of 0.82. These findings highlight the usefulness of the inexpensive and probably underused leukocyte formula in the ICU.

Similarly, the presence of hypoxic hepatitis—defined as the presence of a transient increase in serum aminotransferase activity of over 20 times the upper limit of the normal range in the absence of putative causes of liver necrosis (virus, drugs)—in patients with cardiocirculatory or respiratory failure was carefully scrutinised in a large cohort of 1,066 patients admitted to a medical ICU [21]. The mortality of the 118 patients who fulfilled the criteria of hypoxic hepatitis was indeed increased, especially in the subgroup of patients who required vasopressor therapy. After adjustment, the presence of hypoxic hepatitis was found to be a strong independent risk factor for mortality in patients receiving vasopressor therapy.

Another common finding is corticosteroid insufficiency related to critical illness, a condition associated with increased mortality. The diagnosis of this condition is challenging, as the usefulness of the ACTH test as well as the type of cortisol assay that should be used are still debated. Molenaar et al. [22] compared the values of total and free cortisol after an ACTH test. They found in a set of 112 patients (49 with sepsis) that the diagnosis of adrenal failure was not affected by the type of test used, as free and total cortisol measurements were closely related. These findings could have important implications for daily practice.

Predictors of outcome of sepsis and physiopathological insights

The search for biomarkers of sepsis outcome is an intense field of clinical research. Several new potential markers were assessed and validated by different teams who published their reports in the journal in 2011. An early rise in circulating endothelial protein C was found to be associated with a high mortality [23]. This finding confirms the activation of coagulation at the initial stage of sepsis, and suggests a pathogenetic role for endothelial protein C in the pathway.

In another study [24], the concentration of cardiac troponin T detected by a high-sensitivity assay was found to be elevated in all patients with severe sepsis, and this level was correlated with other indices of poor outcome of sepsis, even though it was not found to be an independent predictor of survival. These findings further support the presence of myocardial injury in sepsis, in proportion to the severity of the sepsis, consistent with other data.

Likewise, the risk of acquisition of a second infection in patients with sepsis was found to be increased when the dendritic cell count was persistently low [25]. A selective depletion of circulating plasmacytoid and myeloid dendritic cells was demonstrated by these authors and by others early after the onset of sepsis. The study suggests that the persistence of low levels increases susceptibility to the development of a second infection, and opens up a large field for further research.

High-mobility group box 1 is a histone that plays a role in the coordination of inflammatory pathways. Barnay-Verdier et al. [26] demonstrated the presence of antibodies directed against high-mobility group box 1 in plasma samples from patients with sepsis. The presence of these antibodies could play a protective role, since the mortality was found to be lower in patients with the highest levels. Moreover, the emergence of these antibodies during the course of sepsis was detected more often in survivors than in nonsurvivors.

The pathogenesis of encephalopathy associated with sepsis could include mitochondrial dysfunction. Therefore, mutations and polymorphisms of mitochondrial DNA might affect the cerebral response to sepsis. In a well-defined cohort of Chinese patients with sepsis, Yang et al. [27] found that a haplogroup of mitochondrial DNA was a strong predictive factor for the development of septic encephalopathy. If confirmed in other populations, such findings pave the way for genomic research in the ICU.

In another exciting line of clinical research, the metabolic alterations of subcutaneous fat tissue were characterised by microdialysis [28]. These researchers found that tissue glycerol and glucose levels were higher during septic shock than during severe sepsis. In contrast, lactate, pyruvate and lactate-to-pyruvate ratios were similar in both conditions. These important findings are likely to change our understanding of the role of fat tissue in the metabolic response to sepsis.

Nutrition and therapeutics

In 2011, several important findings in the fields of metabolism and therapy were reported in the journal. These were new physiopathological insights based on commonly recorded data, or more sophisticated approaches using cutting-edge technologies. New therapeutic advances were presented as well.

Blood glucose concentration and glucose metabolism continuous to be a major topic of interest and is still controversial. During the last decade, neither the most cited study in Intensive Care Medicine [29] nor the largest interventional study published in Intensive Care Medicine [30] has been able to settle the issue of tight glucose control. During 2011, Mackenzie et al. [31] contributed with a systematic analysis of a local database containing blood glucose concentrations and outcomes using a metric methodology. In principle, three different measures that influenced outcomes in terms of mortality were identified out of the blood glucose concentrations; hyperglycaemia, hypoglycaemia, and glucose variability. Needless to say, the study did not include the possibility of differentiating the relative predictive values of the three measures, but as pointed out by Krinsley [32] in an accompanying editorial, future studies of blood glucose control cannot avoid including all three measures.

Meyfroidt et al. [33] from the working group who presented the initial report on tight glucose control, reported the advantage of an automatic predefined blood glucose threshold. The incidence of hypoglycaemia was reduced by 1/3, but the variability of blood glucose was not affected.

The difficulties involved in feeding critically ill patients by the enteral route are well recognised. Often it is gastric emptying that is the problem. Nguyen et al. [34] have investigated the absorption of fat and carbohydrates in the small intestine in relation to motility following surgical repair of abdominal aortic aneurysms. Motility was impaired as compared to controls. This resulted in reduced absorbtion of both fat and carbohydrate. Over time, it was demonstrated that the reduced fat absorbtion was more prolonged after the surgical procedure. This technique opens up interesting possibilities and seems suited for use in evaluations of other groups of critically ill patients, and perhaps to guide the composition of enteral formulations as suggested by the authors.

The optimal nutrition of critical ill patients is a really hot topic, in particular after the EPaNIC study favouring delayed parenteral nutrition [35]. The TICACOS study by Singer et al. [36] is a pilot study in mechanically ventilated patients (n = 112) employing a bundle comprising supervised nutrition intervention including indirect calorimetry, as compared to a body weight guided protocol. The indirect calorimetry group received a higher intake of calories and protein, demonstrating the feasibility of indirect calorimetry. The fact that higher intake was also associated with a longer ICU stay is in total accord with the abovementioned EPaNIC study. As pointed out in an accompanying editorial, the use of indirect calorimetry should be recommended to individualise nutrition, extending follow-up beyond the doors of the hospital [37].

Another important part of nutrition is selenium supplementation, as most countries in Europe have a low natural abundance of selenium, and inflammatory states lower the plasma concentration further. Recent studies have demonstrated a survival advantage of selenium supplementation [38]. Manzanares et al. [39] report a study with high selenium supplementation: 2.0 mg as a bolus followed by 1.6 mg/24 h for 10 days. The high dose of selenium resulted in stimulation of glutathione peroxidase and a lower incidence of hospital-acquired pneumonias. The clinical advantage in terms of morbidity in this comparatively small study (n = 35) indicates that prompt restoration of selenium status early in the course of critical illness is important.

The muscle protein depletion seen during critical illness is present in all age groups. Tuvdendorj et al. [40] report quantitative measurements of skeletal muscle protein turnover, including separate measurements of the synthesis rate and the degradation rate in patients with extensive burn injuries. Muscle protein degradation was increased regardless of age, but the synthesis rate was higher in children, resulting in a significantly better protein net balance in children. This finding is in line with earlier clinical reports of separate studies in children and adults of protein turnover in critical illness, but this finding of Tuvdendorj et al. is original, as it has never before been demonstrated in a homogeneous patient population dichotomised for age. Still, the generalisability beyond burn injury remains to be demonstrated.

Modulating oxidative stress by increasing endogenous antioxidant defence mechanisms has already been intensively investigated. A new set of data was presented in the journal this year [41]. The administration of pharmacological doses of selenium for 14 days in 75 patients with systemic inflammation or sepsis allowed an increase in glutathione peroxidase activity as compared to 75 untreated patients. However, no change was found in mortality, even in subgroups of patients stratified by severity of disease or organ failures. The modalities and indications for antioxidant strategies should definitely be carefully scrutinised in the future. Paraquat intoxication is a prototypical example of oxidative stress associated with high mortality. In such cases, therapeutic options and antidotes are scarce. A new treatment algorithm (high-dose cyclophosphamide + high-dose methylprednisolone) has been assessed and compared to the previous treatment (cyclophosphamide + dexamethasone) in a very large cohort of 111 patients with paraquat poisoning [42]. Mortality was decreased from 92 to 66% in patients randomised to the new algorithm. These important results obviously bring a major contribution to the field of toxicology.


Searching for markers of cerebral vasospasm

The occurrence of symptomatic cerebral vasospasm (SCV) after aneurysmal subarachnoid haemorrhage (aSAH) is a frequent clinical condition that is unfortunately associated with worsened morbidity and mortality [43, 44]. The ability to predict patients at high risk for vasospasm would help in targeting early therapeutical efforts. So far, this has remained an unsatisfied plea [45]. In the ICU, clinical assessment by bedside evaluation is of limited usefulness due to sedation or clinical severity. Transcranial Doppler is a useful screening tool for middle cerebral artery vasospasm, with less utility in evaluating other intracranial vessels, and computed tomographic perfusion may help predict vasospasm when used early during the clinical course [46]. Due to the difficulties involved in identifying SCV, several early markers that could be used to provide therapies focused on early brain damage signs have been search for, with the aims being to prevent but also reduce the intensity of later developing neurological complications [47]. Turck [48] used an awkward panel including four brain injury-related proteins, one cardiac marker and a clinical score, and demonstrated that this is a valuable albeit complex tool for identifying aSAH patients at risk of poor outcome.

Recently, pentraxin 3 (PTX3), a protein induced by proinflammatory signals produced by neutrophils, macrophages, myeloid dendritic and endothelial cells, has emerged as a key player in local inflammatory and ischaemic events, and it has been proposed as a valuable prognostic and diagnostic tool in many conditions, substantiating the evidence that PTX3 has useful features for a potential biomarker. In this context, Zanier [49] investigated the concentrations of PTX3 and its relation with SCV in the plasma and cerebrospinal fluid (CSF) of 38 aSAH patients. PTX3 was elevated in all SAH patients in both plasma and CSF. Early, acute peak CSF PTX3 was significantly higher in patients who later developed vasospasm [median 13.6 (range 2.3–51.9) ng/ml] compared to those who did not [3.2 (0.1–50.5) ng/ml, p = 0.03]. The temporal pattern of CSF PTX3 in patients with vasospasm was triphasic, with a peak during the first 48 h after SAH, a subsequent decrease in the following 48–96 h, and a secondary significant increase with the occurrence of vasospasm. The measurement of CSF PTX3 can improve early diagnosis of this complication, and will be evaluated as a potential early biomarker in further researches. Even if we are improving in the identification of potential biomarkers to use as an early warning for CVS, this search is not yet concluded, and in the future we will probably ameliorate our comprehension in this exciting field.

Barbiturate therapy for refractory ICP

High intracranial pressure (HICP) frequently complicates severe traumatic brain injury, aSAH and other neurological disorders. Raised intracranial pressure has been consistently associated with poor neurological outcome. Treggiari [50], in a systematic review of trauma patients, evaluated the management of raised ICP and related neurological outcomes. ICP refractory to therapy and the response to treatment are very good predictors of neurological outcome compared to absolute ICP values. Relative to normal ICP, raised ICP was associated with a 3.5- to 6.9-fold increase in mortality. Raised but reducible ICP was associated with a 3- to 4-fold increase in the probability of death or poor neurological outcome. Refractory ICP pattern was associated with a dramatic increase in the relative risk of death (odds ratio >110). The same applies to aSAH patients [51].

Our efforts at controlling HICP encompass the use of first-line therapies (CSF withdrawal, sedation, osmotics, hyperventilation, CPP optimisation). If all of these fail and the patient is salvable, we are obliged to use “second-tier” therapies, including barbiturates, hypothermia and decompressive craniectomy. High doses of barbiturates are still recommended to control HICP refractory after the failure of maximal standard medical and surgical therapy [52]. Along with many other severe side effects, the most important being haemodynamic instability and pulmonary complications, dyskalaemia has been described as a severe adverse effect in case reports [53, 54]. Thiopentone inhibits voltage-dependent potassium currents and inhibits phosphofructokinase, causing intracellular sequestration of potassium during its administration and an extracellular release when it is stopped. For this reason, the discontinuation of the drug must not be abrupt; it has to be slowly tapered. However, the real incidence and characteristics of dyskalaemia during and after barbiturate coma have not been well described. Ng et al. [55] performed a retrospective review of all 47 patients who received barbiturate therapy for refractory HICP during an 18-month period in a neurosurgical ICU. 89.4% of the barbiturate patients’ cohort developed hypokalaemia after the induction of barbiturate therapy. The median time to onset of hypokalaemia was 11 h and the time to nadir of serum potassium levels was 25 h. More importantly, 34% patients developed hyperkalaemia on weaning off barbiturate therapy. All patients who developed hyperkalaemia had previously been hypokalaemic. The mean potassium replaced during hypokalaemia was higher in patients who developed hyperkalaemia compared to those who did not. Therefore, hypokalaemia and hyperkalaemia are frequently associated with induction and cessation of barbiturate coma. Serum potassium levels must be monitored vigilantly. Patients who develop hypokalaemia and receive large potassium replacement may be at greater risk of hyperkalaemia on cessation. Hyperkalaemia at cessation has been described as cause of cardiac arrest in this population.

Cerebral monitoring

Not all monitors give you the same numbers! The physiological idea behind cerebral oxygen monitoring is that the PbrO2 value accurately represents the balance between oxygen delivery and oxygen consumption in brain cells, and that changes in PbrO2 will therefore reflect pathophysiological alterations. These changes could then be used to guide treatments to prevent or mitigate hypoxic injury [56]. PbrO2 has been frequently monitored using a Licox system (LX, Integra Neuroscience, Biot, France), the only available device until a couple of years ago. Recently, a different manufacturer (Raumedic, Münchberg, Germany) introduced a new probe, the Neurovent-PTO (NV). Dengler [57] compared the performance of the two systems in 11 comatose traumatic brain injury (TBI) or aSAH patients during dynamic changes in inspirational oxygen fraction and mean arterial pressure. PbrO2 was recorded continuously in patients using the two probes which were placed side-by-side in the same cerebrovascular region. Once a steady baseline value was reached, FiO2 was increased by 20% for 10 min. Once the baseline was again achieved, MAP was increased by 20 mmHg for 10 min. The PbrO2 values of both probes differed significantly at all times. The LX probe reacted significantly faster to changes in FiO2 and MAP. Limits of agreement ranged between −32.1 and 20.0 mmHg. Mean LX values were 6.1 mmHg lower than NV values. Even if the examined patient cohort was rather small, the data suggest that LX and NV probes measure different PbrO2 values in routine monitoring as well as during phases of dynamic changes in FiO2 and MAP. These data therefore do not support the view that both probes can be used interchangeably. The practical advice for the clinician is to be aware of the performance of the system they are using and to adapt treatment thresholds accordingly.

Lescot and co-workers [58] tested intracranial pressure monitors in a study on neurosurgical intensive care patients. They used the Pressio and the Codman devices and compared the results with direct intraventricular measurement. They found that both pressure monitors approximated intraventricular cerebrospinal fluid pressure with an accuracy of ±7 mmHg, a result that may be acceptable under many clinical conditions.

In another study, the brain temperature was measured using two different magnetic resonance techniques [59]. Healthy volunteers were exposed to intranasal cooling, and brain temperature changes were measured and mapped using MR spectroscopic imaging and phase-mapping techniques. The decrease in brain temperature assessed by MR was −1.7°C by spectroscopic imaging and −1.8°C by phase mapping at the end of 1 h of nasal cooling. The rectal temperature fell by 0.5°C. Thus, the simple nasal cooling technique had a substantial effect on brain temperature.

Ethical and legal issues

End-of-life care in specific countries

During 2011 in Intensive Care Medicine, there were three articles that focused on end-of-life care in specific countries. First, Solarino and colleagues conducted a national survey of Italian physicians following the a high profile death of a 36-year-old woman who had been in a vegetative state for 17 years [60]. The Italian Supreme Court granted the woman’s father his wish to discontinue nutrition and hydration. The authors of this paper emailed a questionnaire to 70,000 physicians working for the Italian Public Health System and University Medical Hospitals. 22,219 doctors responded, representing a response rate of 32%. Approximately three-quarters had experience in treating patients in a persistent vegetative state. Approximately 60% of them considered tube feeding to be a medical therapy, and 66% believed that withdrawing artificial nutrition and hydration could be appropriate if based on the patient’s wishes. There was broad consensus among Italian physicians that a clear legislative position regarding the withdrawal of artificial nutrition and hydration is needed.

Second, Weng and colleagues [61] conducted an anonymous survey of the attitude of Chinese intensivists toward end-of-life care in the ICU. Although no list of Chinese intensivists exists, they used an innovative snowball method to identify 534 potential participants from 21 regions in China. The response rate was 59%. The authors found that approximately 60% of physicians reported admitting patients with very poor prognosis to the ICU, and only 19% reported giving complete information to the patients and their families. The use of do-not-resuscitate orders or the limitation of life-sustaining therapy in terminally ill patients was uncommon. Interestingly, the authors compared their results to studies using the same survey in Hong Kong and in Europe. Intensivists in China were equally likely to admit patients with poor prognosis to the ICU as those in Hong Kong and Europe, but were less likely to report withholding or withdrawing life support.

Finally, Kubler and colleagues [62] reported the results of a survey of intensivists attending a national intensive care congress in Poland. Of the 400 questionnaires distributed, 54% were returned. Almost all respondents (93%) reported that they had withheld life support, and 75% of the respondents reported that they had withdrawn life support. Older physicians and those who reported no religious affiliation were more likely to report withholding life support. Respondents from large hospitals (>400 beds) were also more likely to report foregoing life support in ICU patients. These results were similar to a study conducted in Western Europe using the same questionnaire.

Communication and collaboration in end-of-life care

A qualitative study by Lind and colleagues [63] studied family members’ experiences of end-of-life decision-making in Norwegian ICUs, in order to ascertain the degree to which the family felt informed and included in decision-making. The authors used a grounded theory method of qualitative analysis with interviews of 27 bereaved family members. This study found that family members wanted a more active role in decision-making, in order to be able to communicate the values and preferences of the patient. The authors also found that clinicians often used a “wait and see” strategy to address decision-making early in the ICU stay, which many family members experienced as unnecessarily delaying the family members’ ability to come to terms with the severity of the patient’s illness and to participate in decision-making. Family members also discussed the importance of communication with ICU nurses. The authors suggest that ICU clinicians need more training in the knowledge and skills of effective communication with families of critically ill patients.

Jensen and colleagues [64] conducted a survey of nurses and physicians in the ICU as well as physicians in primary care to examine communication and collaboration between ICU and primary care clinicians regarding decisions to forego life support in the ICU. The study was conducted in seven hospitals in Southern Denmark. Participants included 495 ICU nurses, 135 ICU physicians, and 146 primary physicians, with an overall response rate of 84%. Among primary care physicians, approximately 60% found their experience of collaboration to be satisfactory, compared to only 36% of ICU physicians and 27% of ICU nurses. ICU physicians and nurses were more likely than primary care physicians to perceive that decisions regarding withdrawal of life support were unnecessarily postponed due to communication between ICU and primary care clinicians. The authors suggest that multidisciplinary patient conferences, nurse involvement in the decision-making process, and guidelines for foregoing life support might improve communication and collaboration.

End-of-life care in paediatric ICUs

Cremer and colleagues [65] conducted a multicentre prospective observational study to assess the prevalence of questioning about the appropriateness of initiating or maintaining life support in 15 French-speaking paediatric ICUs, and to evaluate decision-making processes. Among the 5,602 children admitted, 410 died (7%) and 175 of those (43% of the deaths) died after foregoing life support. The utility of life support was questioned in 308 children (6%) with a prevalence of 13 per 100 patient-days. More than 30% of the children survived despite the appropriateness of life support being questioned, and 23% survived despite a decision to forego life support. The median clinician time spent on making and presenting decisions about the utility of life support was considerable at 11 h per child. On any given day in each paediatric ICU, there was more than one child for whom a decision to forego life support was being considered, representing a significant amount of paediatric ICU clinicians’ time, and suggesting that this is an important part of paediatric intensive care.

Devictor and colleagues [66] conducted a multicenter prospective study, the Eurydice II study, in 45 paediatric ICUs in Europe. They identified decisions to forego life support in 166 children, representing 41% of the paediatric deaths. They found some regional variability, with more patients dying after CPR in Eastern and Central Europe than in Northern and Western Europe. The vast majority of decisions to forego life support were discussed by clinicians and families during a formal family meeting, after which the medical staff generally made the final decision. The decision was almost always documented in the medical record. The majority of parents were informed of the final decision and were at the bedside during their child’s death. Decisions were made to forego life-sustaining treatment in 41% of children who died, which was higher than the 33% seen in Eurydice I conducted in 2002, 6–7 years earlier. Eurydice II found that a higher percentage of parents were now informed about the meeting and its conclusion as compared with the earlier Eurydice I. This study shows a trend towards the standardisation of paediatric end-of-life practices across European countries in the past decade, with increased communication with the parents of critically ill children.

Resource allocation and identification of organ donors

Kohn and colleagues [67] sent questionnaires to a national sample of US ICU clinicians, soliciting their preferences for allocating their last bed to a gravely ill patient with little chance of surviving versus a deceased or dying patient for whom aggressive management could help others through organ donation. The authors received completed surveys from 684 of 2,206 physicians (31%) and 438 of 988 nurses (44%). They found that physicians were more likely than nurses to adhere to the “rule of rescue” by allocating the last bed to the gravely ill patient (46 vs. 33%). The magnitude of the social benefit to be obtained through organ donor management (5 or 30 life-years added for transplant recipients) had small and inconsistent effects on clinicians’ willingness to prioritise the donor. The most common reason for allocating the last bed to an identifiable patient was that clinicians perceived strong obligations to identifiable living patients.

The authors argue that this allegiance to the rule of rescue will be a major challenge for efforts to develop ethical and standardised ICU triage practices.

In order to identify a potential organ donor as early as possible and maximise the donor conversion rate, it is important to study this conversion rate. However, the donor conversion rate is calculated with different assessment tools, making it difficult to compare across studies and centres. de Groot and colleagues [68] conducted a study to determine which assessment tool can be used for a realistic estimation of a potential organ donor pool, and how they compare to each other with regard to the donor conversion rate. They conducted a retrospective chart review of patients diagnosed with a subarachnoid haemorrhage, traumatic brain injury, or intracerebral haemorrhage, and applied three different assessment tools. In their cohort of patients, 179 out of 564 (32%) died. After applying three different assessment tools, the number of patients found to be brain dead, before exclusion due to medical reasons or age, ranged from 76 to 107 patients. The authors identified one tool that was the most practical for identifying patients with a realistic chance of becoming brain dead and therefore identifying the patients most likely to become a potential organ donor.


Acute lung injury and mechanical ventilation

Most previous studies have focused on the propagation of epithelial and endothelial injury in ALI/ARDS; the ability of bacteria to colonise host defense mechanisms are not well studied in this pathophysiologic process. Piccin and colleagues [69] examined the hypothesis that mechanical ventilation directly affects respiratory defense mechanisms (the mucociliary system). The authors used different modes of mechanical ventilation in rabbits, and demonstrated that mechanical ventilation using high volume and high pressure led to detrimental changes in the large proximal airway mucociliary system compared with lower tidal volume ventilation. Although a significant decrease in tracheal mucus secretion was noted across all ventilated groups, only animals ventilated with high pressures showed a significant reduction in ciliary beating frequency. The authors speculated that the mucociliary alterations occurred as a result of tissue hypoperfusion caused by mechanical ventilation with high pressures and high airway flows. An editorial [70] pointed out that the relevance of the observation is yet to be investigated in patients under mechanical ventilation. It is nevertheless important to understand the effects of changes in mucociliary clearance in the context of ventilator-induced lung injury that may alter host susceptibility to infections or prolonged intubations due to secretion retention.

Mechanical ventilation with high tidal volume increased the generation of reactive oxygen stress (ROS), cytokine responses, and the activation of mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB associated with lung injury [71]. In an isolated, perfused rat model, the administration of apocynin, a strong oxidative inhibitor known to block nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in neutrophils, macrophages, and endothelium [72, 73, 74], depressed oxidative stress, attenuated inflammatory responses, and reduced ventilator-induced lung injury (VILI) [71].

Resolution of the alveolar epithelial/capillary membrane damage that occurs during acute lung injury (ALI) requires a coordinated and effective tissue reconstruction program to re-establish a functional barrier [75]. Regeneration of alveolar epithelial cells and matrix turnover are controlled by regulatory pathways, while dysregulation of these pathways may result in amplification of the initial injury and disorderly repair, with sustained inflammation and development of pulmonary fibrosis [76, 77]. Since WNT/β-catenin signaling has been reported to be involved in epithelial cell injury [78], Villar et al. [79] demonstrated that this pathway is modulated early during ventilator-induced lung injury. This modulation may represent a promising therapeutic target for attenuating or preventing the pathological consequences of acute lung injury.

The mechanisms of ventilator-induced diaphragmatic damage (VIDD) are not fully elucidated [80]. Previous studies have shown that high tidal volume ventilation leads to the activation of serine/threonine kinase/protein kinase B (Akt) and c-Jun NH2-terminal kinase (JNKs) [81]. Activation of the phosphoinositide 3-OH kinase (PI3-K)/Akt pathway also results in the phosphorylation of the class O of forkhead box transcription factor (Foxo) proteins [82]. Li et al. demonstrated that a high tidal volume ventilation-induced diaphragmatic damage model was associated with the activation of JNK and Foxo4, and this process was dependent on the Akt and JNK pathways. These data help us to understand the effects of mechanical forces on the diaphragmatic injury, as well as suggest whether inhibiting the Akt and JNK pathways offers possible treatment options [83].

Previous studies have shown that high-dose corticosteroids or neuromuscular blocking agents (NMBA) [84] may affect diaphragm function [85]. Maes et al. [86] hypothesised that the combination of rocuronium (NMBA) and corticosteroids would result in a further deterioration of diaphragm function in a model of ventilator-induced diaphragm dysfunction (VIDD). They observed that the negative effect of rocuronium infusion with controlled mechanical ventilation was absent with the administration of a high dose of corticosteroid due to inhibition of the calpain and caspase-3 system.

It has been suggested that the airway pressure used in the mechanical ventilation of patients with ALI/ARDS should be in-between the low and upper inflection points of the pressure–volume (PV) curve. During constant inspiratory flow, analysis of the airway pressure–time profile (Pt) can replace the static PV curve [87]. From the mathematical point of view, the airway pressure can be described as a function of inspiratory time by the following equation: airway pressure = at b  + c, where the coefficient b, called the stress index, describes the shape of the Pt curve during a tidal breath. If b < 1, it means that the compliance increases, suggesting tidal recruitment; if b = 1, it suggests that the compliance does not change, while if b > 1, it indicates compliance decreases, suggesting tidal overinflation [88]. Formenti et al. [89] tested the predictive ability of the stress index compared with quantitative lung CT scan in paralysed, mechanically ventilated pigs. The tests were conducted at PEEP values of 1 and 10 cm H2O in the absence and presence of pleural effusion by fluid instillation in pleural space. The investigators demonstrated a dissociation between the stress index, which suggested lung overinflation, and the CT scan, which showed lung recruitment. This observation suggests that the ability of the stress index to predict lung recruitment and overdistension was significantly reduced in the pathophysiological conditions. However, the authors did not measure the transpulmonary pressure in their study. An editorial [90] suggests that computation of the stress index as usually obtained from the airway pressure curve should be replaced by analysis of the transpulmonary pressure curve profile. In the heterogeneous airspace environment of ALI/ARDS, a reliable tool at the bedside to set desirable PEEP and VT is critical [91]. Traditional methods of monitoring lung mechanics using the pressure–volume curve, static compliance and the stress index have shown drawbacks, especially when the compliance of the chest wall is altered. Computed tomography (CT) scan is a powerful tool for mapping the distribution of the gas volume, but it is yet to be a part of bedside technology. The forced oscillation technique (FOT) may offer several potential advantages over traditional methods because it applies very small volume displacement, it minimises artifacts resulting from nonlinearity of the respiratory system, and it does not require deep sedation and muscle paralysis. Using FOT in a surfactant depletion model of ALI, Dellaca and colleagues [92] performed incremental and decremental PEEP trials, and measured both conventional and FOT-derived respiratory system compliance at each step of PEEP changes. CT scan analysis was performed as a gold standard for monitoring lung compartments at end expiration. FOT was able to detect the minimal PEEP value needed to keep the lung open, and this was in good agreement with CT scan analysis with respect to sensitivity and specificity, suggesting that FOT may have potential value in defining adequate levels of PEEP to prevent/reduce the occurrence of de-recruitment. However, the validation of FOT to detect the extent of recruitment/de-recruitment and hyperinflation remains to be determined in more complicated clinical situations [93]. Variable ventilation is a new mode delivering volume-controlled ventilation with variation of the tidal volume around an average value. Pillow et al. [94] found that variable ventilation increased dynamic compliance but not static compliance or oxygenation in preterm lambs. They also found decreased PaCO2 and concluded that variable ventilation was more efficient than conventional ventilation. The authors speculated that the lack of improvement in oxygenation between the groups was due to right to left shunt. However, one may argue that the pulmonary vascular resistance might have decreased with the observed improvement in compliance and reduced CO2 levels, thus resulting in better pulmonary blood flow and oxygenation. Further investigations are needed to address the effects of variable ventilation in physiological and pathological conditions.

The gradient between end-tidal partial pressure of CO2 (PETCO2) and arterial partial pressure of CO2 (PaCO2) (PET-aCO2) in mechanically ventilated patients presents a wide range of variation [95]. The reduction of the PET-aCO2 gradient can be achieved in spontaneously breathing healthy humans using an end-inspiratory rebreathing technique, which equilibrates end-tidal, alveolar, arterial and venous PCO2. Based on the aforementioned, Fierstra et al. [96] investigated whether this method would reduce the PET-aCO2 gradient in a ventilated animal model. This technique led to a reduction in the PET-aCO2 gradient, while the precision of PETCO2 as a surrogate for PaCO2 was independent of the PaCO2, PaO2, and SaO2 as well as the extent of lung disease. Therefore, the end-inspiratory rebreathing technique may allow precise, noninvasive monitoring of PaCO2 in ventilated patients, but further studies are required to identify the limitations of the method.

Monitoring of airway systems

Bohr’s dead space (VDBohr) measurement is commonly calculated using end-tidal CO2 instead of the true alveolar partial pressure of CO2 (PACO2). Tusman et al. [97] compared the measurement of VDBohr using PACO2 derived from either volumetric capnography or the standard alveolar air formula. The authors concluded that VDBohr can be calculated with accuracy using volumetric capnography. In a correspondence letter, Graf [98] expressed concerns about using Bohr’s formula for measuring physiological dead space. The measurement may refer to airway (VDaw) but not alveolar (VDalv) fraction. The letter also argued that using CO2 as a tracer of overall ventilatory efficiency still requires the measurement of VCO2, expired minute ventilation and PaCO2. The value of PaCO2 may be increased by shunt and/or V/Q inequalities, leading to physiological dead space overestimation. This is an interesting topic, and more studies and discussion are encouraged to clarify this issue. Despite all of the technical advances of recent years, auscultation provides both useful physiological information and close patient–physician interaction. Today, there are automated systems that are available to detect, analyse, and interpret lung sounds. Image-based techniques of lung sound analysis such as vibration response imaging have been introduced and tested clinically. However, studies are warranted to determine their potential role in clinical practice. Vena et al. [99] report an analysis of the spectral characteristics of lung sounds. They observed significant correlation between intratidal recruitment measured with dynamic CT and the degree of crackles in the sound analysis, suggesting that air passage through atelectasis as well as poorly aerated areas is crucial for generating lung crackle sounds. They concluded that the computer-based analysis of crackle sounds is more sensitive for differentiating between small differences in healthy and injured conditions, especially at higher positive end-expiratory pressure (PEEP) levels, compared to conventional clinical auscultation. This simple and noninvasive technique of computer-based lung sound analysis may help intensivists monitor mechanical ventilation and diagnostic or therapeutic procedures such as recruitment manoeuvres in real time at the bedside. Yet the validation of the technique, and the variation of frequent measurements and interpretation of complex respiratory signals to optimise ventilator settings or to detect alveolar recruitment, especially in injured lungs, remain to be further investigated at the bedside [100]. Endotracheal tubes at high volume and low-pressure cuffs may fail to protect the lower airway from leakage of potentially contaminated secretions below the longitudinal folds. Ouanes et al. [101] studied the effects of PEEP levels, inspiratory effort intensity, peak pressures, tracheal tube cuff materials and sizes on the leakage of fluids past the cuff in an in vitro model of tracheal intubation and mechanical ventilation. The authors observed that leakage occurred more frequently at lower levels of PEEP, higher inspiratory efforts were associated with higher leakage, and polyurethane cuffs performed better than polyvinylchloride cuffs. In theory, most aspiration during mechanical ventilation occurs when tracheal pressure falls below hydrostatic pressure. Thus, the most important dependent variables are PEEP, inspiratory efforts and duty cycles. More studies are required to examine the effects of mechanical ventilation on leakage across the cuff.

Lung and distal organ interactions

It is becoming increasingly apparent that lung and brain represent an integrated physiological ensemble such that insults involving one will compromise the other and vice versa [102]. Severe neurological injury is associated with concurrent lung injury in clinical settings. Recent studies have shown that acute lung injury may be responsible for brain injury and poor neurocognitive outcomes. However, the underlying biological mechanisms are yet to be elucidated. Heuer et al. [103] evaluated the independent and combined effects of sustained acute intracranial hypertension (AICH) and ARDS on lung injury and brain damage in a porcine model. They observed that markers of lung injury were augmented with AICH and rose further with concurrent AICH/ARDS. These observations shed valuable light on the complex process of signaling, involving neural, inflammatory, immunological, and neuroendocrine pathways. The fundamental physiological mechanisms still need to be addressed in future studies investigating whether the brain injury was due to increased capillary permeability, and whether the brain edema was vasogenic or cytotoxic. Given the significant epidemiologic and mechanistic overlap between sepsis and ALI/ARDS, it seems plausible that some of the known effects of sepsis on the brain may be relevant to brain dysfunction encountered in ALI/ARDS [102].

The brain is one of the first organs affected during sepsis development; however, the mechanisms associated with septic encephalopathy are not well known [104]. Comim et al. hypothesised that during sepsis, brain cytokines and chemokines may lead to alterations in the blood–brain barrier (BBB) permeability, resulting in an increase in the flux of inflammatory cells and toxic mediators into the brain, thus contributing to injury. They demonstrated that the brain’s production of cytokines and chemokines was an early event during sepsis, and seemed to participate in both central nervous system dysfunction and BBB permeability alterations [105].

Studies are needed to demonstrate these links to enable the development of specific therapeutic strategies.

Since there is increasing interest in the use of both pulse pressure variation (PPV) and stroke volume variation (SVV) to predict preload responsiveness and drive resuscitation protocols, Mesguida et al. [106] evaluated the impact of increasing tidal volume, decreased chest wall compliance, and left ventricular contractility during intermittent positive-pressure ventilation (IPPV) on the relation between PPV and left ventricular stroke volume variation and intrathoracic blood volume changes in dogs. This study provides a systematic examination of the changes in the right and left heart pressure and stroke volumes during the ventilator cycle. The author’s major conclusion is that there is tight coupling between pulse pressure and left ventricular SVV. The authors have also added some important new information that shows the effect of changes in chest wall compliance, tidal volume and left ventricular function on the measurements. It is noteworthy that a proper quantitative analysis would require integrating the area under the stroke volume curves of all the stroke volumes in inspiration and expiration. What the author is really showing is that there are transient differences between the right and left side peak stroke volumes that must be associated with gains or losses of pulmonary vascular volume to fulfil the conservation of mass.

Biomarkers, treatment of hypoxia and sepsis

Reliable biomarkers of sepsis are needed for early diagnosis and guidance of appropriate treatment.

Pentraxin 3 (PTX3) is expressed in a variety of cells, including inflammatory (e.g. macrophages, neutrophils, dendritic cells), endothelial, and epithelial cells. Additionally, the PTX3 level is well correlated with the severity of lung injury and multiple organ failure, and may serve as a biomarker for ALI/ARDS [107]. In order to analyse the role of PTX3 in an LPS-induced ALI model, PTX3 knock-out (PTX3-KO) mice were used, and more severe lung tissue injuries, neutrophil infiltration, cell death, activation of the coagulation cascade, and inflammatory responses were observed, indicating that PTX3 plays a protective role in the pathogenesis of ALI [108].

Izquierdo-Garcia et al. [109] conducted a study in rats where lung tissue, lung lavage fluids and serum samples were profiled from caecal ligation and puncture-induced sepsis and control groups using NMR and high-resolution magic angle spinning detection. Predictive PLS-DA models were constructed based on the NMR spectra of the three types of biological samples and employed to diagnose sepsis in other samples. The authors further reported that the predictive power obtained by combining the three types of samples was 100%. An advantage of employing metabolomics for potential diagnosis is the utilisation of biofluids and/or easily accessible tissues. Because lung tissue collection is invasive, while sepsis often appears in critically ill patients, the use of lung tissue for metabolomic analysis is not practical at the bedside. Moreover, bacteria play a key role in sepsis, particularly in conditions like peritonitis-associated sepsis. However, bacterium-related information was absent from their study. Therefore, the diagnostic value of the clinical treatment provided by this study is limited. Future studies may need to include urine samples for metabolomic analysis in order to understand bacterium-specific metabolites.

Several mechanisms have been proposed to explain vascular dysfunction induced by sepsis [110]. Experimental studies have shown that selective and nonselective inhibitors of vascular potassium (K+) channels increase arterial pressure or reverse shock-induced vascular hyporeactivity [111]. However, while the use of channel inhibitors remains an attractive option to counteract systemic vasodilation, it may also impair microcirculatory adaptation to shock [112]. Collin et al. [113] demonstrated that vascular K+ channels are activated and overexpressed, while their inhibition restores arterial pressure and vascular reactivity, and decreases lactate concentration, thus offering potential therapeutic perspectives for septic shock.

In the search for treatments for critical illnesses, levosimendan has been found to be interesting candidate, as it is a potent stimulator of vascular ATP-dependent potassium channels (K+-ATP channels), inducing systemic vasodilation and reducing afterload. Schwarte et al. [114] examined the effect of levosimendan on cardiac output and tissue perfusion in the presence of hypoxia in a canine model. They found that when levosimendan was infused before hypoxia was induced, myocardial contractility, stroke volume and cardiac output were preserved in spite of the hypoxic insult. The novelty of this study is the examination of the antagonising effect of glibenclamide on the action of levosimendan. When given alone, glibenclamide caused a rise in systemic vascular resistance, suggesting that glibenclamide was acting to block K+-ATP channels. When levosimendan was administered in the presence of glibenclamide, levosimendan caused a significant rise in cardiac output by improving myocardial contractility. This is indicative of levosimendan acting through a calcium-sensitising effect rather than on K+-ATP channels. In a separate study, Revermann et al. [115] reported that the administration of levosimendan and nicorandil (a K+-channel opener) attenuated the increased pulmonary vascular medial wall thickness in a model of pulmonary hypertension induced by monocrotaline challenge. Levosimendan significantly diminished the proliferation of pulmonary arterial smooth muscle cells, and this effect was attenuated by glibenclamide. In cell culture, levosimendan had a direct inhibitory effect on the platelet-derived growth factor induced proliferation of pulmonary arterial smooth muscle cells. These findings of levosimendan exerting inotropic, vasodilatory and anti-inflammatory properties under experimental conditions are exciting, but the real promise for levosimendan as a therapeutic candidate to support critical illness remains to be elucidated. Further in vitro and animal studies are required to understand the vasodilatory action of levosimendan, and the consequent effects—positive or negative—on end-organ perfusion [116]. Acute kidney injury is a common complication in patients with sepsis.

The primary resuscitation strategy for these patients is fluid resuscitation to improve organ perfusion and oxygenation and thereby prevent distal organ failure. Legrand et al. [117] examined the effects of fluid resuscitation on renal perfusion in relation to renal microcirculatory function in endotoxemic rats. The authors observed that infusion of endotoxin resulted in altered microvascular perfusion and oxygenation distributions. Early fluid resuscitation greatly improved renal perfusion compared to late resuscitation, but it did not influence oxygenation distribution. Serum cytokine levels decreased in the resuscitated groups, no matter whether early or late resuscitation was involved. Although the results are interesting, one has to keep in mind that the study was conducted at 300 min after endotoxin administration, and it is unknown whether this time frame is long enough to fully assess the therapeutic value of immediate versus delayed resuscitation in clinical situations. There are several issues that need to be addressed in future studies. For example, the volume and rate of fluid administration could simply have altered the disposition of endotoxin in the kidney. It is unclear how dramatic differences in aortic and renal artery flow and microvascular flow between endotoxin alone and endotoxin with fluid resuscitation had no impact on microvascular oxygen tension. Since the human erythropoietin fusion protein (EPO) gene was cloned over 25 years ago, several variants of the EPO molecule have been developed to improve its pharmacokinetic and pharmacodynamic characteristics and to separate its haemopoietic and neuroprotective properties [118]. For example, carbamylated erythropoietin fusion protein (cEPO-FC) contains two recombinant human EPO (rhEPO) molecules connected by the Fc region of human IgG1, and is thought to improve the cytoprotective effects while reducing side effects including hypertension and thrombosis. Simon et al. [119] report that pretreatment with a cEPO-FC is as effective as rhEPO in ameliorating spinal cord injury in a porcine model of acute spinal cord ischaemia and reperfusion. This study assessed short-term outcomes, including motor-evoked potentials and histological damage. Future studies will need to focus on the longer-term neurological outcomes and demonstrate an absence of systemic toxicity, including thrombosis. It is noteworthy that clinical studies raised the possibility that rhEPO could improve some clinical outcomes, including neuronal recovery, but rhEPO failed to show any clinical benefit with respect to the Barthel index, modified Rankin scale and mortality rate in patients with stroke [120, 121]. Thus, further experimental and clinical research is needed to determine if derivatives of rhEPO such as cEPO-FC can improve long-term neurological outcome without having potential adverse effects such as hypertension, thrombosis and mortality. Reactive oxygen species are produced by activated neutrophils during the inflammatory response to stimuli such as endotoxins, can directly or indirectly injure host cells, and have been implicated in the pathogenesis of ALI/ARDS. Hassett et al. [122] described the result of pulmonary overexpression of superoxide dismutase in the response to endotoxin administration in animals. Endotoxin produced a severe lung injury compared to a sham injury. Their results support the conclusion that superoxide dismutase plays an important role in lung injury in terms of neutrophil infiltration, cytokine responses, lung edema and histology. However, the delivery technique for the superoxide dismutase transgene—using adeno-associated virus—remains controversial. The conclusion that gene therapy may be appropriate for ALI is a bit premature and need further studies.

Sepsis affects both oxygen delivery to tissues, through cardiac and macro- and microcirculatory alterations [123], and oxygen consumption, through effects on mitochondrial respiration [124]. Dyson et al. reported that the early fall in tissue oxygenation was associated with both macro- and microcirculatory impairment, the latter persisting despite restoration of the macrocirculation. However, by 24 h, this impairment had largely recovered, even though the animal predicted to have a poor prognosis were then manifesting clinical and biochemical signs of organ dysfunction, suggesting that cellular abnormalities were enhanced at this later stage [125]. Therefore, the utility of tissue PO2 monitoring to highlight the local oxygen supply–demand balance, and dynamic O2 challenge testing to assess microcirculatory function, merits further investigation.

The benefits of stress-dose steroid therapy and recombinant activated protein C (APC) in septic shock remain controversial [126]. Bouazza et al. [127] hypothesised that the combination of APC and steroids would be beneficial compared with their individual use in resuscitated septic shock induced by caecal ligation and puncture. They observed that either APC or dexamethasone improved arterial contractility and endothelial dysfunction resulting from septic shock; however, their combination increased survival, thus recommending the re-evaluation of the combined use of APC and steroids. The conclusion of the PROWESS-SHOCK study (still unpublished) that led to the retraction of the APC from the market has eliminated this molecule from clinical use.

Sepsis is associated with massive discharges of catecholamine and consequent persistent stimulation of the β-adrenergic receptor [128]. Selective β1-adrenergic blockers might present a new therapeutic capability against sepsis [129], although the exact mechanism remains to be elucidated. Mori et al. [130] observed that esmolol, a selective β1-blocker, improved outcome in a rat model of sepsis by preventing gut barrier dysfunction and thereby bacterial translocation.

Modulating the adrenergic system may be a new approach to the treatment of sepsis [131]. In rats with peritonitis, β1-blockade decreased proinflammatory cytokines and improved cardiac function and haemodynamics [129]. However, so far, no study has evaluated the haemodynamic tolerance of esmolol—a selective ultrashort-acting β1-blocker—in large animals with endotoxemic shock. Therefore, Aboab et al. [132] observed that selective β1-blockade was well tolerated in endotoxemic pigs treated with a continuous infusion of esmolol, and prevented sepsis-induced cardiac dysfunction, confirming findings reported in small animals.

Oxidative stress has an important role in the development of the systemic inflammatory response [133]. Honokiol, a low molecular weight natural product, is an effective antioxidant and also presents anti-inflammatory and antitumor properties [134]. However, the precise mechanism of action of honokiol on septic acute lung injury remains unclear. Weng et al. [135] observed that honokiol administered after the onset of sepsis reduced acute lung injury and prolonged survival via the amelioration of oxidative stress in endotoxemic mice.

Tumor necrosis factor (TNF)-α has been implicated in the pathogenesis of septic shock. TNF inhibitors resulted in increased survival in experimental sepsis [136]; however, no anti-TNF agent modified survival in clinical sepsis trials [137]. Fluid therapy may itself have anti-inflammatory effects [138], but is rarely employed in preclinical sepsis models. Therefore, Qiu et al. [139] analysed whether the combination of TNFsr and fluids would be beneficial. They reported that the individual survival benefits of TNFsr and fluids were not additive in a rat sepsis model.

Multiple organ dysfunction syndrome (MODS) is defined as the progressive deterioration of function that occurs in several organs or systems in patients with septic shock. Zymosan-induced generalised inflammation reproduces the characteristics of human MODS, and has been used to evaluate new therapies [140]. Rinaldi et al. investigated the effects of hyperbaric oxygen (HBO) exposure on the expression of Toll-like receptors (TLR) 2 and 4, on their signal transduction, and on organ dysfunction during zymosan-induced MODS. They reported that the anti-inflammatory effect of HBO is associated with the inhibition of TLR signaling, and suggest that HBO therapy is effective at reducing systemic inflammation and associated organ dysfunction in this model [141].

Reactive oxygen species (ROS) are believed to be involved in electrical shock (ES) related myocardial injury [142], ischaemia/reperfusion injury, reperfusion arrhythmia, and cardiogenic shock. Ascorbic acid, a potent water-soluble antioxidant, has been found to attenuate oxidative damage, myocardial injury, and arrhythmia during reperfusion [143]. However, so far, no in vivo study has evaluated whether ascorbic acid administration benefits defibrillation and resuscitation. Therefore, Tsai et al. [144], in a rat model of ventricular fibrillation and electrical shock, observed that the intravenous administration of ascorbic acid at the start of cardiopulmonary resuscitation reduced lipid peroxidation and myocardial necrosis, diminished mitochondrial damage, facilitated resuscitation, and improved outcome.


  1. 1.
    Martensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333–1340PubMedGoogle Scholar
  2. 2.
    Bouman CS, Forni LG, Joannidis M (2010) Biomarkers and acute kidney injury: dining with the Fisher King? Intensive Care Med 36:381–384PubMedGoogle Scholar
  3. 3.
    Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE, Schultz MJ, Bouman CS (2011) Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 37:493–501PubMedGoogle Scholar
  4. 4.
    Hasslacher J, Lehner GF, Joannidis M (2011) Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology. Intensive Care Med 38:170–171Google Scholar
  5. 5.
    Darmon M, Schortgen F, Vargas F, Liazydi A, Schlemmer B, Brun-Buisson C, Brochard L (2011) Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Med 37:68–76PubMedGoogle Scholar
  6. 6.
    Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE (2011) Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 37:60–67PubMedGoogle Scholar
  7. 7.
    Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J (2011) Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 37:1921–1931PubMedGoogle Scholar
  8. 8.
    Pettila V, Webb SA, Bailey M, Howe B, Seppelt IM, Bellomo R (2011) Acute kidney injury in patients with influenza A (H1N1) 2009. Intensive Care Med 37:763–767PubMedGoogle Scholar
  9. 9.
    Nin N, Lorente JA, Soto L, Rios F, Hurtado J, Arancibia F, Ugarte S, Echevarria E, Cardinal P, Saldarini F, Bagnulo H, Cortes I, Bujedo G, Ortega C, Frutos F, Esteban A (2011) Acute kidney injury in critically ill patients with 2009 influenza A (H1N1) viral pneumonia: an observational study. Intensive Care Med 37:768–774PubMedGoogle Scholar
  10. 10.
    Nin N, Lorente JA, Sanchez-Rodriguez C, Granados R, Ver LS, Soto L, Hidalgo J, Fernandez-Segoviano P, Ortin J, Esteban A (2011) Kidney histopathological findings in fatal pandemic 2009 influenza A (H1N1). Intensive Care Med 37:880–881PubMedGoogle Scholar
  11. 11.
    Joannidis M, Forni LG (2011) Severe viral infection and the kidney: lessons learned from the H1N1 pandemic. Intensive Care Med 37:729–731PubMedGoogle Scholar
  12. 12.
    Joannidis M, Metnitz PG (2005) Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 21:239–249PubMedGoogle Scholar
  13. 13.
    Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J (2011) Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med 37:241–248PubMedGoogle Scholar
  14. 14.
    Berry PA, Antoniades CG, Carey I, McPhail MJ, Hussain MJ, Davies ET, Wendon JA, Vergani D (2011) Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med 37:453–460PubMedGoogle Scholar
  15. 15.
    Rhodes A, Moreno RP, Metnitz B, Hochrieser H, Bauer P, Metnitz P (2011) Epidemiology and outcome following post-surgical admission to critical care. Intensive Care Med 37:1466–1472PubMedGoogle Scholar
  16. 16.
    Mohnle P, Snyder-Ramos SA, Miao Y, Kulier A, Bottiger BW, Levin J, Mangano DT (2011) Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med 37:97–109PubMedGoogle Scholar
  17. 17.
    Hutagalung R, Marques J, Kobylka K, Zeidan M, Kabisch B, Brunkhorst F, Reinhart K, Sakr Y (2011) The obesity paradox in surgical intensive care unit patients. Intensive Care Med 37:1793–1799PubMedGoogle Scholar
  18. 18.
    Druml W, Metnitz B, Schaden E, Bauer P, Metnitz PG (2010) Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med 36:1221–1228PubMedGoogle Scholar
  19. 19.
    Ettema RG, Peelen LM, Kalkman CJ, Nierich AP, Moons KG, Schuurmans MJ (2011) Predicting prolonged intensive care unit stays in older cardiac surgery patients: a validation study. Intensive Care Med 37:1480–1487PubMedGoogle Scholar
  20. 20.
    Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N, Khoudri I, Zeggwagh AA, Abouqal R (2011) Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 37:1136–1142PubMedGoogle Scholar
  21. 21.
    Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schoniger-Hekele M, Madl C, Schenk P (2011) Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37:1302–1310PubMedGoogle Scholar
  22. 22.
    Molenaar N, Johan Groeneveld AB, Dijstelbloem HM, de Jong MF, Girbes AR, Heijboer AC, Beishuizen A (2011) Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med 37:1986–1993PubMedGoogle Scholar
  23. 23.
    Guitton C, Gerard N, Sebille V, Bretonniere C, Zambon O, Villers D, Charreau B (2011) Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis. Intensive Care Med 37:950–956PubMedGoogle Scholar
  24. 24.
    Rosjo H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettila V, Omland T (2011) Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 37:77–85PubMedGoogle Scholar
  25. 25.
    Grimaldi D, Louis S, Pene F, Sirgo G, Rousseau C, Claessens YE, Vimeux L, Cariou A, Mira JP, Hosmalin A, Chiche JD (2011) Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intensive Care Med 37:1438–1446PubMedGoogle Scholar
  26. 26.
    Barnay-Verdier S, Fattoum L, Borde C, Kaveri S, Gibot S, Marechal V (2011) Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock. Intensive Care Med 37:957–962PubMedGoogle Scholar
  27. 27.
    Yang Y, Zhang P, Lv R, He Q, Zhu Y, Yang X, Chen J (2011) Mitochondrial DNA haplogroup R in the Han population and recovery from septic encephalopathy. Intensive Care Med 37:1613–1619PubMedGoogle Scholar
  28. 28.
    Kopterides P, Nikitas N, Vassiliadi D, Orfanos SE, Theodorakopoulou M, Ilias I, Boutati E, Dimitriadis G, Maratou E, Diamantakis A, Armaganidis A, Ungerstedt U, Dimopoulou I (2011) Microdialysis-assessed interstitium alterations during sepsis: relationship to stage, infection, and pathogen. Intensive Care Med 37:1756–1764PubMedGoogle Scholar
  29. 29.
    van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedGoogle Scholar
  30. 30.
    Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297PubMedGoogle Scholar
  31. 31.
    Mackenzie IM, Whitehouse T, Nightingale PG (2011) The metrics of glycaemic control in critical care. Intensive Care Med 37:435–443PubMedGoogle Scholar
  32. 32.
    Krinsley JS (2011) Understanding glycemic control in the critically ill: three domains are better than one. Intensive Care Med 37:382–384PubMedGoogle Scholar
  33. 33.
    Meyfroidt G, Wouters P, De Becker W, Cottem D, Van den Berghe G (2011) Impact of a computer-generated alert system on the quality of tight glycemic control. Intensive Care Med 37:1151–1157PubMedGoogle Scholar
  34. 34.
    Nguyen NQ, Besanko LK, Burgstad CM, Burnett J, Stanley B, Butler R, Holloway RH, Fraser RJ (2011) Relationship between altered small intestinal motility and absorption after abdominal aortic aneurysm repair. Intensive Care Med 37:610–618PubMedGoogle Scholar
  35. 35.
    Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G (2011) Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365:506–517PubMedGoogle Scholar
  36. 36.
    Singer P, Anbar R, Cohen J, Shapiro H, Shalita-Chesner M, Lev S, Grozovski E, Theilla M, Frishman S, Madar Z (2011) The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med 37:601–609PubMedGoogle Scholar
  37. 37.
    Wernerman J (2011) Individualized ICU nutrition for a better outcome. Intensive Care Med 37:564–565PubMedGoogle Scholar
  38. 38.
    Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R (2007) Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:118–126PubMedGoogle Scholar
  39. 39.
    Manzanares W, Biestro A, Torre MH, Galusso F, Facchin G, Hardy G (2011) High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med 37:1120–1127PubMedGoogle Scholar
  40. 40.
    Tuvdendorj D, Chinkes DL, Zhang XJ, Ferrando AA, Elijah IE, Mlcak RP, Finnerty CC, Wolfe RR, Herndon DN (2011) Adult patients are more catabolic than children during acute phase after burn injury: a retrospective analysis on muscle protein kinetics. Intensive Care Med 37:1317–1322PubMedGoogle Scholar
  41. 41.
    Valenta J, Brodska H, Drabek T, Hendl J, Kazda A (2011) High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 37:808–815PubMedGoogle Scholar
  42. 42.
    Lin JL, Lin-Tan DT, Chen KH, Huang WH, Hsu CW, Hsu HH, Yen TH (2011) Improved survival in severe paraquat poisoning with repeated pulse therapy of cyclophosphamide and steroids. Intensive Care Med 37:1006–1013PubMedGoogle Scholar
  43. 43.
    Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr (1987) Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 37:1586–1591PubMedGoogle Scholar
  44. 44.
    Coppadoro A, Citerio G (2011) Subarachnoid hemorrhage: an update for the intensivist. Minerva Anestesiol 77:74–84PubMedGoogle Scholar
  45. 45.
    Diringer MN, Bleck TP, Claude Hemphill 3rd J, Menon D, Shutter L, Vespa P, Bruder N, Connolly Jr ES, Citerio G, Gress D, Hanggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15:211–240Google Scholar
  46. 46.
    Washington CW, Zipfel GJ (2011) Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit Care 15:312–317PubMedGoogle Scholar
  47. 47.
    Sehba FA, Pluta RM, Zhang JH (2011) Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 43:27–40PubMedGoogle Scholar
  48. 48.
    Turck N, Vutskits L, Sanchez-Pena P, Robin X, Hainard A, Gex-Fabry M, Fouda C, Bassem H, Mueller M, Lisacek F, Puybasset L, Sanchez JC (2010) A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med 36:107–115PubMedGoogle Scholar
  49. 49.
    Zanier ER, Brandi G, Peri G, Longhi L, Zoerle T, Tettamanti M, Garlanda C, Sigurta A, Valaperta S, Mantovani A, De Simoni MG, Stocchetti N (2011) Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. Intensive Care Med 37:302–309PubMedGoogle Scholar
  50. 50.
    Treggiari MM, Schutz N, Yanez ND, Romand JA (2007) Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care 6:104–112PubMedGoogle Scholar
  51. 51.
    Heuer GG, Smith MJ, Elliott JP, Winn HR, LeRoux PD (2004) Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 101:408–416PubMedGoogle Scholar
  52. 52.
    Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW, Rosenthal G, Schouten J, Shutter L, Timmons SD, Ullman JS, Videtta W, Wilberger JE, Wright DW (2007) Guidelines for the management of severe traumatic brain injury. XI. Anesthetics, analgesics, and sedatives. J Neurotrauma 24 Suppl 1:S71–76Google Scholar
  53. 53.
    Magira EE, Sakellaridis K, Tselioti P, Grammatikopoulou B, Prekates A (2011) Severe hyperkalemia induced by a short interruption of barbiturate coma. Intensive Care Med 37:362–363PubMedGoogle Scholar
  54. 54.
    Neil MJ, Dale MC (2009) Hypokalaemia with severe rebound hyperkalaemia after therapeutic barbiturate coma. Anesth Analg 108:1867–1868PubMedGoogle Scholar
  55. 55.
    Ng SY, Chin KJ, Kwek TK (2011) Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series. Intensive Care Med 37:1285–1289PubMedGoogle Scholar
  56. 56.
    Andrews PJ, Citerio G, Longhi L, Polderman K, Sahuquillo J, Vajkoczy P (2008) NICEM consensus on neurological monitoring in acute neurological disease. Intensive Care Med 34:1362–1370PubMedGoogle Scholar
  57. 57.
    Dengler J, Frenzel C, Vajkoczy P, Wolf S, Horn P (2011) Cerebral tissue oxygenation measured by two different probes: challenges and interpretation. Intensive Care Med 37:1809–1815PubMedGoogle Scholar
  58. 58.
    Lescot T, Reina V, Le Manach Y, Boroli F, Chauvet D, Boch AL, Puybasset L (2011) In vivo accuracy of two intraparenchymal intracranial pressure monitors. Intensive Care Med 37:875–879PubMedGoogle Scholar
  59. 59.
    Covaciu L, Weis J, Bengtsson C, Allers M, Lunderquist A, Ahlstrom H, Rubertsson S (2011) Brain temperature in volunteers subjected to intranasal cooling. Intensive Care Med 37:1277–1284PubMedGoogle Scholar
  60. 60.
    Solarino B, Bruno F, Frati G, Dell’erba A, Frati P (2011) A national survey of Italian physicians’ attitudes towards end-of-life decisions following the death of Eluana Englaro. Intensive Care Med 37:542–549PubMedGoogle Scholar
  61. 61.
    Weng L, Joynt GM, Lee A, Du B, Leung P, Peng J, Gomersall CD, Hu X, Yap HY (2011) Attitudes towards ethical problems in critical care medicine: the Chinese perspective. Intensive Care Med 37:655–664PubMedGoogle Scholar
  62. 62.
    Kubler A, Adamik B, Lipinska-Gediga M, Kedziora J, Strozecki L (2011) End-of-life attitudes of intensive care physicians in Poland: results of a national survey. Intensive Care Med 37:1290–1296PubMedGoogle Scholar
  63. 63.
    Lind R, Lorem GF, Nortvedt P, Hevroy O (2011) Family members’ experiences of “wait and see” as a communication strategy in end-of-life decisions. Intensive Care Med 37:1143–1150PubMedGoogle Scholar
  64. 64.
    Jensen HI, Ammentorp J, Erlandsen M, Ording H (2011) Withholding or withdrawing therapy in intensive care units: an analysis of collaboration among healthcare professionals. Intensive Care Med 37:1696–1705PubMedGoogle Scholar
  65. 65.
    Cremer R, Hubert P, Grandbastien B, Moutel G, Leclerc F (2011) Prevalence of questioning regarding life-sustaining treatment and time utilisation by forgoing treatment in francophone PICUs. Intensive Care Med 37:1648–1655PubMedGoogle Scholar
  66. 66.
    Devictor DJ, Latour JM (2011) Forgoing life support: how the decision is made in European pediatric intensive care units. Intensive Care Med 37:1881–1887PubMedGoogle Scholar
  67. 67.
    Kohn R, Rubenfeld GD, Levy MM, Ubel PA, Halpern SD (2011) Rule of rescue or the good of the many? An analysis of physicians’ and nurses’ preferences for allocating ICU beds. Intensive Care Med 37:1210–1217PubMedGoogle Scholar
  68. 68.
    de Groot YJ, Wijdicks EF, van der Jagt M, Bakker J, Lingsma HF, Ijzermans JN, Kompanje EJ (2011) Donor conversion rates depend on the assessment tools used in the evaluation of potential organ donors. Intensive Care Med 37:665–670PubMedGoogle Scholar
  69. 69.
    Piccin VS, Calciolari C, Yoshizaki K, Gomes S, Albertini-Yagi C, Dolhnikoff M, Macchione M, Caldini EG, Saldiva PH, Negri EM (2011) Effects of different mechanical ventilation strategies on the mucociliary system. Intensive Care Med 37:132–140PubMedGoogle Scholar
  70. 70.
    Yamashita CM, Veldhuizen RA (2011) Swept under the carpet? The role of mucociliary clearance in ventilator-induced lung injury. Intensive Care Med 37:4–6PubMedGoogle Scholar
  71. 71.
    Chiang CH, Chuang CH, Liu SL, Lee TS, Kou YR, Zhang H (2011) Apocynin attenuates ventilator-induced lung injury in an isolated and perfused rat lung model. Intensive Care Med 37:1360–1367PubMedGoogle Scholar
  72. 72.
    Dodd OJ, Pearse DB (2000) Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 279:H303–H312Google Scholar
  73. 73.
    Muijsers RB, van Den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS, Nijkamp FP (2000) Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol 130:932–936PubMedGoogle Scholar
  74. 74.
    Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F, O’Donnell RW, Chang MM, Hogg MG, Dordick JS, Santhanam L, Ziegler LM, Holland JA (2002) Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 9:191–203PubMedGoogle Scholar
  75. 75.
    Chao MC, Garcia CS, de Oliveira MB, Santos RS, Lucas IH, Silva PL, Vieira-Abreu A, de Castro-Faria-Neto HC, Parra-Cuentas ER, Capelozzi VL, Pelosi P, Rocco PR (2010) Degree of endothelium injury promotes fibroelastogenesis in experimental acute lung injury. Respir Physiol Neurobiol 173:179–188PubMedGoogle Scholar
  76. 76.
    Horowitz JC, Cui Z, Moore TA, Meier TR, Reddy RC, Toews GB, Standiford TJ, Thannickal VJ (2006) Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 290:L415–L425PubMedGoogle Scholar
  77. 77.
    Pelosi P, Rocco PR (2008) Effects of mechanical ventilation on the extracellular matrix. Intensive Care Med 34:631–639PubMedGoogle Scholar
  78. 78.
    Douglas IS, Diaz del Valle F, Winn RA, Voelkel NF (2006) Beta-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol 34:274–285PubMedGoogle Scholar
  79. 79.
    Villar J, Cabrera NE, Casula M, Valladares F, Flores C, Lopez-Aguilar J, Blanch L, Zhang H, Kacmarek RM, Slutsky AS (2011) WNT/beta-catenin signaling is modulated by mechanical ventilation in an experimental model of acute lung injury. Intensive Care Med 37:1201–1209PubMedGoogle Scholar
  80. 80.
    Vassilakopoulos T (2008) Ventilator-induced diaphragm dysfunction: the clinical relevance of animal models. Intensive Care Med 34:7–16PubMedGoogle Scholar
  81. 81.
    Li LF, Yu L, Quinn DA (2004) Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase. Am J Respir Crit Care Med 169:518–524PubMedGoogle Scholar
  82. 82.
    Pardo PS, Lopez MA, Boriek AM (2008) FOXO transcription factors are mechanosensitive and their regulation is altered with aging in the respiratory pump. Am J Physiol Cell Physiol 294:C1056–C1066PubMedGoogle Scholar
  83. 83.
    Li LF, Tien ML, Leung SY, Lin MC (2011) High tidal volume mechanical ventilation elicits increased activity in protein kinase B and c-Jun NH(2)-terminal kinase pathways in mouse diaphragm. Intensive Care Med 37:2015–2022PubMedGoogle Scholar
  84. 84.
    Testelmans D, Maes K, Wouters P, Gosselin N, Deruisseau K, Powers S, Sciot R, Decramer M, Gayan-Ramirez G (2006) Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med 34:3018–3023PubMedGoogle Scholar
  85. 85.
    Behbehani NA, Al-Mane F, D’Yachkova Y, Pare P, FitzGerald JM (1999) Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115:1627–1631PubMedGoogle Scholar
  86. 86.
    Maes K, Testelmans D, Thomas D, Decramer M, Gayan-Ramirez G (2011) High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function. Intensive Care Med 37:1865–1872PubMedGoogle Scholar
  87. 87.
    Ranieri VM, Giuliani R, Fiore T, Dambrosio M, Milic-Emili J (1994) Volume–pressure curve of the respiratory system predicts effects of PEEP in ARDS: “occlusion” versus “constant flow” technique. Am J Respir Crit Care Med 149:19–27Google Scholar
  88. 88.
    Ranieri VM, Zhang H, Mascia L, Aubin M, Lin CY, Mullen JB, Grasso S, Binnie M, Volgyesi GA, Eng P, Slutsky AS (2000) Pressure–time curve predicts minimally injurious ventilatory strategy in an isolated rat lung model. Anesthesiology 93:1320–1328Google Scholar
  89. 89.
    Formenti P, Graf J, Santos A, Gard KE, Faltesek K, Adams AB, Dries DJ, Marini JJ (2011) Non-pulmonary factors strongly influence the stress index. Intensive Care Med 37:594–600PubMedGoogle Scholar
  90. 90.
    Chiumello D, Gattinoni L (2011) Stress index in presence of pleural effusion: does it have any meaning? Intensive Care Med 37:561–563PubMedGoogle Scholar
  91. 91.
    Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, De Backer D, Gerlach H, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Pugin J, Wernerman J, Zhang H (2011) Year in review in Intensive Care Medicine 2010: III. ARDS and ALI, mechanical ventilation, noninvasive ventilation, weaning, endotracheal intubation, lung ultrasound and paediatrics. Intensive Care Med 37:394–410PubMedGoogle Scholar
  92. 92.
    Dellaca RL, Zannin E, Kostic P, Olerud MA, Pompilio PP, Hedenstierna G, Pedotti A, Frykholm P (2011) Optimisation of positive end-expiratory pressure by forced oscillation technique in a lavage model of acute lung injury. Intensive Care Med 37:1021–1030PubMedGoogle Scholar
  93. 93.
    Fanelli V, Spieth P, Zhang H (2011) Forced oscillation technique: an alternative tool to define the optimal PEEP? Intensive Care Med 37:1235–1237PubMedGoogle Scholar
  94. 94.
    Pillow JJ, Musk GC, McLean CM, Polglase GR, Dalton RG, Jobe AH, Suki B (2011) Variable ventilation improves ventilation and lung compliance in preterm lambs. Intensive Care Med 37:1352–1359PubMedGoogle Scholar
  95. 95.
    McDonald MJ, Montgomery VL, Cerrito PB, Parrish CJ, Boland KA, Sullivan JE (2002) Comparison of end-tidal CO2 and PaCO2 in children receiving mechanical ventilation. Pediatr Crit Care Med 3:244–249PubMedGoogle Scholar
  96. 96.
    Fierstra J, Machina M, Battisti-Charbonney A, Duffin J, Fisher JA, Minkovich L (2011) End-inspiratory rebreathing reduces the end-tidal to arterial PCO2 gradient in mechanically ventilated pigs. Intensive Care Med 37:1543–1550PubMedGoogle Scholar
  97. 97.
    Tusman G, Sipmann FS, Borges JB, Hedenstierna G, Bohm SH (2011) Validation of Bohr dead space measured by volumetric capnography. Intensive Care Med 37:870–874PubMedGoogle Scholar
  98. 98.
    Graf J (2011) Comment on Tusman et al.: Validation of Bohr dead space measured by volumetric capnography. Intensive Care Med 37:1396 (author reply 1397–1398)Google Scholar
  99. 99.
    Vena A, Rylander C, Perchiazzi G, Giuliani R, Hedenstierna G (2011) Lung sound analysis correlates to injury and recruitment as identified by computed tomography: an experimental study. Intensive Care Med 37:1378–1383PubMedGoogle Scholar
  100. 100.
    Spieth PM, Zhang H (2011) Analyzing lung crackle sounds: stethoscopes and beyond. Intensive Care Med 37:1238–1239PubMedGoogle Scholar
  101. 101.
    Ouanes I, Lyazidi A, Danin PE, Rana N, Di Bari A, Abroug F, Louis B, Brochard L (2011) Mechanical influences on fluid leakage past the tracheal tube cuff in a benchtop model. Intensive Care Med 37:695–700PubMedGoogle Scholar
  102. 102.
    Stevens RD, Puybasset L (2011) The brain–lung–brain axis. Intensive Care Med 37:1054–1056Google Scholar
  103. 103.
    Heuer JF, Pelosi P, Hermann P, Perske C, Crozier TA, Bruck W, Quintel M (2011) Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage: a randomized experimental study in pigs. Intensive Care Med 37:1182–1191PubMedGoogle Scholar
  104. 104.
    Streck EL, Comim CM, Barichello T, Quevedo J (2008) The septic brain. Neurochem Res 33:2171–2177PubMedGoogle Scholar
  105. 105.
    Comim CM, Vilela MC, Constantino LS, Petronilho F, Vuolo F, Lacerda-Queiroz N, Rodrigues DH, da Rocha JL, Teixeira AL, Quevedo J, Dal-Pizzol F (2011) Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med 37:711–718PubMedGoogle Scholar
  106. 106.
    Mesquida J, Kim HK, Pinsky MR (2011) Effect of tidal volume, intrathoracic pressure, and cardiac contractility on variations in pulse pressure, stroke volume, and intrathoracic blood volume. Intensive Care Med 37:1672–1679PubMedGoogle Scholar
  107. 107.
    Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti A, Mantovani A (2010) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36:621–629PubMedGoogle Scholar
  108. 108.
    Han B, Haitsma JJ, Zhang Y, Bai X, Rubacha M, Keshavjee S, Zhang H, Liu M (2011) Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury. Intensive Care Med 37:334–342PubMedGoogle Scholar
  109. 109.
    Izquierdo-Garcia JL, Nin N, Ruiz-Cabello J, Rojas Y, de Paula M, Lopez-Cuenca S, Morales L, Martinez-Caro L, Fernandez-Segoviano P, Esteban A, Lorente JA (2011) A metabolomic approach for diagnosis of experimental sepsis. Intensive Care MedGoogle Scholar
  110. 110.
    Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63–78PubMedGoogle Scholar
  111. 111.
    Buckley JF, Singer M, Clapp LH (2006) Role of KATP channels in sepsis. Cardiovasc Res 72:220–230PubMedGoogle Scholar
  112. 112.
    Lange M, Morelli A, Ertmer C, Broking K, Rehberg S, Van Aken H, Traber DL, Westphal M (2007) Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications. Shock 28:394–400PubMedGoogle Scholar
  113. 113.
    Collin S, Sennoun N, Dron AG, de la Bourdonnaye M, Montemont C, Asfar P, Lacolley P, Meziani F, Levy B (2011) Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock. Intensive Care Med 37:861–869PubMedGoogle Scholar
  114. 114.
    Schwarte LA, Schwartges I, Thomas K, Schober P, Picker O (2011) The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia. Intensive Care Med 37:701–710PubMedGoogle Scholar
  115. 115.
    Revermann M, Schloss M, Mieth A, Babelova A, Schroder K, Neofitidou S, Buerkl J, Kirschning T, Schermuly RT, Hofstetter C, Brandes RP (2011) Levosimendan attenuates pulmonary vascular remodeling. Intensive Care Med 37:1368–1377PubMedGoogle Scholar
  116. 116.
    Stuart-Smith K (2011) Levosimendan: from coronary care to intensive care? Intensive Care Med 37:569–571PubMedGoogle Scholar
  117. 117.
    Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C (2011) The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med 37:1534–1542PubMedGoogle Scholar
  118. 118.
    Siren AL, Fasshauer T, Bartels C, Ehrenreich H (2009) Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6:108–127PubMedGoogle Scholar
  119. 119.
    Simon F, Scheuerle A, Groger M, Vcelar B, McCook O, Moller P, Georgieff M, Calzia E, Radermacher P, Schelzig H (2011) Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Med 37:1525–1533PubMedGoogle Scholar
  120. 120.
    Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jahnig P, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40:e647–e656PubMedGoogle Scholar
  121. 121.
    Pavenski K, Hare GM, Mazer CD (2011) Erythropoietic neuroprotection: Holy Grail or potential to fail? Intensive Care Med 37:1403–1405PubMedGoogle Scholar
  122. 122.
    Hassett P, Curley GF, Contreras M, Masterson C, Higgins BD, O’Brien T, Devaney J, O’Toole D, Laffey JG (2011) Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury. Intensive Care Med 37:1680–1687PubMedGoogle Scholar
  123. 123.
    Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599–1608PubMedGoogle Scholar
  124. 124.
    Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223PubMedGoogle Scholar
  125. 125.
    Dyson A, Rudiger A, Singer M (2011) Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med 37:1192–1200PubMedGoogle Scholar
  126. 126.
    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60PubMedGoogle Scholar
  127. 127.
    Bouazza Y, Sennoun N, Strub C, Regnault V, Gibot S, Meziani F, Lacolley P, Levy B (2011) Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock. Intensive Care Med 37:1857–1864PubMedGoogle Scholar
  128. 128.
    Norbury WB, Jeschke MG, Herndon DN (2007) Metabolism modulators in sepsis: propranolol. Crit Care Med 35:S616–S620PubMedGoogle Scholar
  129. 129.
    Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R, Poputnikov D, Singer M, Gourine AV (2010) Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 38:388–394PubMedGoogle Scholar
  130. 130.
    Mori K, Morisaki H, Yajima S, Suzuki T, Ishikawa A, Nakamura N, Innami Y, Takeda J (2011) Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med 37:1849–1856PubMedGoogle Scholar
  131. 131.
    de Montmollin E, Aboab J, Mansart A, Annane D (2009) Bench-to-bedside review: beta-adrenergic modulation in sepsis. Crit Care 13:230Google Scholar
  132. 132.
    Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37:1344–1351PubMedGoogle Scholar
  133. 133.
    Mishra V (2007) Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 53:199–209PubMedGoogle Scholar
  134. 134.
    Fried LE, Arbiser JL (2009) Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139–1148PubMedGoogle Scholar
  135. 135.
    Weng TI, Wu HY, Kuo CW, Liu SH (2011) Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation. Intensive Care Med 37:533–541PubMedGoogle Scholar
  136. 136.
    Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662–664PubMedGoogle Scholar
  137. 137.
    Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197–1205PubMedGoogle Scholar
  138. 138.
    Dorresteijn MJ, van Eijk LT, Netea MG, Smits P, van der Hoeven JG, Pickkers P (2005) Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 11:287–293PubMedGoogle Scholar
  139. 139.
    Qiu P, Li Y, Ding Y, Weng J, Banks SM, Kern S, Fitz Y, Suffredini AF, Eichacker PQ, Cui X (2011) The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model. Intensive Care Med 37:1688–1695PubMedGoogle Scholar
  140. 140.
    Ivanovska N, Kalfin R, Lazarova M, Dimitrova P (2007) Exogenous VIP limits zymosan-induced generalized inflammation (ZIGI) in mice. Immunol Lett 110:126–132PubMedGoogle Scholar
  141. 141.
    Rinaldi B, Cuzzocrea S, Donniacuo M, Capuano A, Di Palma D, Imperatore F, Mazzon E, Di Paola R, Sodano L, Rossi F (2011) Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Med 37:1110–1119PubMedGoogle Scholar
  142. 142.
    Tsai MS, Sun S, Tang W, Ristagno G, Chen WJ, Weil MH (2008) Free radicals mediate postshock contractile impairment in cardiomyocytes. Crit Care Med 36:3213–3219PubMedGoogle Scholar
  143. 143.
    Gao F, Yao CL, Gao E, Mo QZ, Yan WL, McLaughlin R, Lopez BL, Christopher TA, Ma XL (2002) Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J Pharmacol Exp Ther 301:543–550PubMedGoogle Scholar
  144. 144.
    Tsai MS, Huang CH, Tsai CY, Chen HW, Lee HC, Cheng HJ, Hsu CY, Wang TD, Chang WT, Chen WJ (2011) Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock. Intensive Care Med 37:2033–2040PubMedGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2012

Authors and Affiliations

  • Massimo Antonelli
    • 1
    Email author
  • Marc Bonten
    • 2
  • Jean Chastre
    • 3
  • Giuseppe Citerio
    • 4
  • Giorgio Conti
    • 1
  • J. Randall Curtis
    • 5
  • Daniel De Backer
    • 6
  • Goran Hedenstierna
    • 7
  • Michael Joannidis
    • 8
  • Duncan Macrae
    • 9
  • Jordi Mancebo
    • 10
  • Salvatore M. Maggiore
    • 1
  • Alexandre Mebazaa
    • 11
  • Jean-Charles Preiser
    • 12
  • Patricia Rocco
    • 13
  • Jean-François Timsit
    • 14
  • Jan Wernerman
    • 15
  • Haibo Zhang
    • 16
  1. 1.Department of Intensive Care and Anesthesiology, Policlinico Universitario A. GemelliUniversità Cattolica del Sacro CuoreRomeItaly
  2. 2.Department of Medical MicrobiologyJulius Center for Health Sciences and Primary Care University Medical Center UtrechtUtrechtThe Netherlands
  3. 3.Reanimation MedicaleHopital Pitié SalpétrièreParisFrance
  4. 4.Neurointensive Care UnitOspedale S. GerardoMonzaItaly
  5. 5.Division of Pulmonary and Critical CareUniversity of WashingtonSeattleUSA
  6. 6.Service des Soins IntensifsErasme HospitalBrusselsBelgium
  7. 7.Department of Clinical PhysiologyUppsala UniversityUppsalaSweden
  8. 8.Department of Internal MedicineMedical University of InnsbruckInnsbruckAustria
  9. 9.Pediatric Intensive Care UnitRoyal Brompton HospitalLondonUK
  10. 10.Intensive Care Medicine UnitHospital Sant PauBarcelonaSpain
  11. 11.Department of Anesthesiology and Critical Care MedicineLariboisière HospitalParisFrance
  12. 12.Department of Intensive CareErasme University HospitalBrusselsBelgium
  13. 13.Laboratory of Pulmonary InvestigationCentro de Ciências da SaúdeRio de JaneiroBrazil
  14. 14.Intensive Care Medicine UnitHôpital A. MichallonGrenobleFrance
  15. 15.Departments of Anesthesiology and Intensive Care MedicineKarolinska University HospitalStockholmSweden
  16. 16.Interdepartmental Division of Critical Care MedicineUniversity of TorontoTorontoCanada

Personalised recommendations